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Abstract
Introduction: Despite high efficacy and safety of tramadol as a pain relieving analgesic, some minor side effects have been reported
following its consumption. However, very rarely, serious and life-threatening side effects may appear following administration of
tramadol.
Case Presentation: This research describes a case of tramadol poisoning that appeared with acute seizure needing emergent and
intensive cares. In the described case, using a low dose of tramadol (200 mg, orally), the patient experienced generalized tonic
colonic seizure followed by loss of consciousness and shoulder dislocation due to trauma, requiring admission to the intensive
care unit.
Conclusions: As shown in the study, even using a low dose of tramadol might lead to acute generalized seizure with loss of con-
sciousness and the need for intensive care.
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1. Introduction
Tramadol is a synthetic 4-phenyl-piperidine analogue
of codeine with a centrally acting analgesic effect (1).
Compared to common opioid analgesics, such as mor-
phine or pethidine, tramadol has a balanced drug efficacy
and safety (2). In comparison with morphine, the anal-
gesic potency of tramadol is approximately 10% of that of
morphine, along with considerable lower side effects (3).
Moreover, tramadol has an acceptable postoperative pain-
relieving effect compared to other analgesics, even in the
parenteral root, particularly in those with increased risk
of postoperative cardiopulmonary complications (4). On
the other hand, adding tramadol to some anesthetic drugs,
such as lidocaine can be appropriate in surgeries because
of accentuating sensory and motor blockade effects with-
out any increase in complications (5). In total, this drug
has been approved as a well-tolerated analgesic drug in
patients, who are candidate for different surgical proce-
dures or those with high load of acute or chronic pains
following severe trauma, chronic malignant conditions,
and colic or neuropathic pain (6). Despite its high efficacy,
some minor side effects have also been reported following
the use of tramadol, including nausea and vomiting, con-
stipation, dysphoria, or even mild respiratory depression
(7). All of these side effects seem to be dose-dependent and
thus considering an optimal dose of drug leads to mini-
mization of its-related side effects. However, serious and
life-threatening side effects may very rarely appear follow-
ing administration of tramadol (8). Herein, this report de-
scribes a case of tramadol poisoning that appeared with
acute seizure, needing emergent and intensive care.
2. Case Presentation
The described case was a 32-year-old male that was ad-
vised to use tramadol (200 mg, orally), as a single dose, be-
cause of appearing severe headache. About half an hour
since using the drug, the patient experienced generalized
tonic colonic seizure that lasted about five minutes and
thus the patient was hospitalized. On admission, the pa-
tient was sleepy and was complaining of pain in both the
hands, particularly in the shoulders. The patient had no
significant history of special disease, drug abuse or addic-
tion. In laboratory tests, urine screening test confirmed
the use of tramadol. Arterial blood gas analysis showed
mixed acidotic disturbances (PH = 7.23, PCO2 = 56 mmHg,
and HCO3 concentration = 19 mmol/L). Due to loss of con-
sciousness, the patient was intubated and admitted to
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the intensive care unit. The subject was extubated after
48 hours of intensive care. Given that the patient still
complained of pain in both shoulders and also limited
movement of the upper limbs, X-ray examination was re-
quested indicating bilateral fractures and dislocation of
both shoulders. Thus, he was a candidate for surgery that
was successfully managed.
3. Discussion
Although some reports are available on seizure as a
rare side effect of high dose tramadol, the occurrence of
this complication following a low dose has not been re-
ported previously. Interestingly, some evidences have em-
phasized that seizure following the use of tramadol is not
dose-dependent (9). In the present report, the researchers
described a case that used a single dose of tramadol 200
mg orally that led to acute generalized seizure requiring
intensive care management. Simultaneously, because of
probable traumatic injuries, he also had shoulder trauma
that was assessed by imaging and managed surgically. In
a similar report by Nakhaei et al. (10), of all patients, who
referred to the emergency ward with shoulder dislocation,
24.4% had tramadol induced seizures and also showed a
significant relationship between the number of disloca-
tion and tramadol use. In another report by Farajidana et
al. (11) of patients with tramadol-induced seizures, 79.7%
had referred within the first 6 hours after drug use. They
also indicated that the prevalence of trauma was 24.6%
with the most frequent site of trauma being the face fol-
lowed by shoulders. Along with studies that assessed the
clinical consequences of tramadol poisoning, some oth-
ers focused on the main determinants of tramadol-related
seizure. In a study by Taghaddosinejad et al. (12), seizure
was significantly correlated with higher reported dose,
and tramadol only to overdose, however, it was neither
related to higher tramadol blood concentrations, nor re-
lated to time elapsed, age, gender, history of addiction, and
observed Glasgow Coma Scale of patients. Thus, in their
study, tramadol-induced seizure was shown to be dose de-
pendent.
As shown in the current study, even using a low dose of
tramadol might lead to acute generalized seizure with loss
of consciousness and need of intensive care. Commonly, it
has been shown that taking high dose of tramadol (as the
therapeutic range) can induce seizure attacks within the
first 24 hours with overall incidence of 84% (13, 14).
Pathophysiologically, the metabolites of tramadol pro-
duced by liver via o-demethylation have a major role in ap-
pearing serotonergic syndrome that has been suggested to
be responsible for seizure. In other words, these metabo-
lites may induce serotonin activity that explains occur-
rence of seizure related to tramadol uptake. In addi-
tion, the use of selective serotonin reuptake inhibitors
can also induce seizure occurrence, another reason for in-
creased risk for seizure following tramadol consumption
(15). However, the risk for generalized seizure after taking
low dose of tramadol has remained uncertain and should
be assessed further.
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